查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1874006

细胞疗法市场

Cell Therapy Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

细胞治疗市场预计将从 2024 年的 102.8 亿美元成长到 2031 年的 167.2 亿美元，2031 年至 2031 年的年复合成长率(CAGR) 为 7.2%。推动该市场成长的关键趋势包括细胞疗法的进步以及领先製造商推出创新产品。

细胞疗法市场分析

再生疗法促进细胞、组织和器官的再生，从而帮助恢復其功能。根据再生医学联盟报告，截至2023年第四季度，全球共有520项涉及细胞疗法药物的临床试验（包括192项I期临床试验、125项II期临床试验及36项III期临床试验）。 2017年，Kymriah获批上市，成为首个获批上市的细胞疗法，这标誌着细胞疗法在细胞和基因治疗领域的重要地位得到了显着提升。 CAR-T细胞（嵌合抗原受体T细胞）疗法的出现彻底改变了癌症的治疗方法。 CAR-T细胞疗法经历了广泛的研究和创新，目前已有五种产品——Yescarta、Abecma、Tecartus、Breyanzi和Carvykti——获准用于治疗多种血液癌症。因此，再生医学应用的不断扩展正在推动细胞疗法市场的成长。

细胞治疗市场概览

CAR-T细胞疗法已成为一种极具前景的癌症治疗手段。每年都有大量的临床前和临床试验开展，以探索其在新的治疗应用中的潜力。未来的研究预计将聚焦于自体和异体CAR-T细胞产品，以及新型体内CAR-T细胞基因疗法及其在血液系统恶性肿瘤以外疾病的疗效。

战略洞察

细胞治疗市场的驱动因素与机会

癌症发生率上升推动市场扩张

久坐的生活方式和饮食习惯的改变等因素被认为是多种慢性疾病的重要风险因素，包括神经系统疾病、癌症、自体免疫疾病和心血管疾病。美国疾病管制与预防中心报告称，十分之六的美国人患有一种或多种慢性疾病，包括糖尿病、癌症、心臟病或中风。慢性疾病是美国死亡和残疾的主要原因。遗传倾向、加工食品、污染和生活方式的改变等因素导致癌症发生率不断上升。美国癌症协会指出，2020年全球新增癌症病例近1,930万例。近几十年来，细胞疗法作为一种新型癌症治疗方法兴起，其原理是在实验室中改造T细胞，然后用于靶向癌细胞。 CAR-T细胞疗法已用于治疗成人和儿童白血病以及某些类型的淋巴瘤，目前正在研究其治疗其他癌症（包括实体瘤）的潜力。因此，癌症患者数量的不断增长推动了对CAR-T细胞疗法的需求，从而促进了细胞疗法市场的成长。

研发经费

鑑于先前接受过治疗的复发/难治性恶性肿瘤患者中细胞疗法的完全缓解率和无进展生存期显着提高，研究人员正致力于探索提升细胞疗法疗效的方法。目前正在研究抗原流失等可能导致免疫逃脱的因素，并制定应对这些挑战的策略。一个很有前景的方法是设计能够同时针对多种抗原的细胞疗法。加州再生医学研究所 (CIRM) 是全球最大的再生医学机构，已拨款 4,380 万美元用于支持加州的基因治疗和干细胞研究项目，资助该研究所的临床、发现和基础设施建设等多个项目。

细胞治疗市场区隔分析

细胞治疗市场分析的关键细分市场包括治疗类型、产品、技术、应用和最终用户。

  • 细胞治疗市场按治疗类型分为同种异体和自体，到 2023 年，同种异体部分将占据更大的市场份额。
  • 按产品划分，市场分为耗材、设备、系统和软体，其中设备部分在 2023 年占据市场份额领先地位。
  • 从技术角度来看，市场涵盖病毒载体技术、基因组编辑技术、体细胞技术、细胞永生化技术、细胞可塑性技术和三维技术。
  • 按应用领域划分，市场分为肿瘤学、心血管、骨科、伤口管理和其他应用领域，其中肿瘤学在 2023 年占据最大的市场份额。
  • 根据最终用户划分，细胞治疗市场分为研究机构、医院和其他机构，其中医院在 2023 年占据了市场份额的主导地位。

细胞治疗市场的地理分析

细胞疗法市场报告的地理范围分为五个地区：北美、亚太、欧洲、中东和非洲以及南美和中美洲。北美市场领先，其中美国在2023年占据最大份额。这一成长归功于研发投入的增加，以及干细胞疗法、基因疗法和免疫疗法等细胞疗法日益普及的现象。遗传和细胞疾病发生率的上升，以及对提升细胞疗法研发和生产能力的重视，进一步推动了市场成长。拜耳公司在柏克莱建立了其首个细胞疗法上市中心，旨在为全球患者提供细胞疗法。这座耗资2.5亿美元、占地10万平方英尺的设施将为后期临床试验提供材料，以促进bemdaneprocel（BRT-DA01）的商业化上市。 bemdaneprocel是由BlueRock Therapeutics公司研发的一种用于治疗帕金森氏症和其他疾病的实验性细胞疗法。预计在预测期内，亚太地区的细胞疗法市场复合年增长率将最高。

细胞疗法市场报告范围

细胞治疗市场最新动态

细胞治疗市场的评估是基于从一手和二手研究中获得的定性和定量资料，包括重要的企业出版物、协会资料和资料库。细胞治疗市场近期的一些发展包括：

  • 专注于建立领先的细胞编程和生物安全平台的Ginkgo Bioworks公司宣布收购Modulus Therapeutics的细胞治疗平台资产，其中包括其CAR和转换受体库。 （资料来源：Ginkgo Bioworks公司，新闻稿，2024）
  • 阿斯特捷利康已达成最终协议，收购全球临床阶段生物製药公司Gracell Biotechnologies Inc.，该公司致力于开发用于治疗癌症和自体免疫疾病的创新细胞疗法。 （资料来源：阿斯特捷利康公司，新闻稿，2024年）

细胞疗法市场报告的覆盖范围和成果

这份题为《细胞疗法市场规模及预测（2021-2031）》的报告对市场进行了全面分析，涵盖以下领域：

  • 细胞治疗市场规模及预测，涵盖全球、区域和国家层面的所有主要市场细分领域。
  • 细胞治疗市场的发展趋势以及市场动态，例如驱动因素、限制因素和关键机会。
  • 深入的 PEST/波特五力模型和 SWOT 分析。
  • 对细胞治疗市场进行分析，涵盖关键趋势、全球和区域框架、主要参与者、法规和近期市场发展。
  • 产业格局和竞争分析，包括市场集中度、热力图分析、主要参与者以及细胞治疗市场的最新发展。
  • 市场主要公司的详细概况。

目录

第一章：引言

第二章：细胞疗法市场及主要结论

第三章：研究方法

  • 覆盖范围
  • 二手研究
  • 初步研究

第四章：全球细胞疗法及市场概况

  • 概述
  • PEST分析
    • 北美和PEST分析
    • 欧洲PEST分析
    • 亚太地区及PEST分析
    • 中东和非洲以及 PEST 分析
    • 南美洲和中美洲以及 PEST 分析
  • 专家意见

第五章：全球细胞治疗市场及关键产业动态

  • 主要市场驱动因素
    • 慢性病盛行率不断上升
    • 再生医学的日益普及
    • 细胞疗法获准数量不断增加
  • 主要市场限制因素
    • 细胞疗法生产成本高昂
  • 主要市场机会
    • 发展中地区细胞疗法的普及率不断提高
  • 未来趋势
    • 向自动化细胞治疗生产转型
  • 驾驶员和约束装置的影响分析

第六章：细胞疗法市场及全球分析

  • 全球细胞疗法市场收入预测与分析
  • 全球细胞治疗市场（依地域划分）－预测与分析
  • 市场定位

第七章：细胞疗法市场分析及依疗法类型划分

  • 概述
  • 细胞疗法市场收入份额（按疗法类型划分，2024 年和 2031 年）
  • 同种异体
  • 自体

第八章：细胞疗法市场分析及产品分类

  • 概述
  • 细胞疗法市场收入份额（按产品划分，2024 年和 2031 年）
  • 消耗品
  • 装置
  • 系统和软体

第九章：细胞疗法市场分析及技术分类

  • 概述
  • 按技术分類的细胞疗法市场收入份额（2024 年和 2031 年）
  • 病毒载体技术
  • 基因组编辑技术
  • 体细胞技术
  • 细胞永生化技术
  • 细胞可塑性技术
  • 三维技术

第十章：细胞疗法市场分析及应用

  • 概述
  • 细胞疗法市场收入份额（按应用领域划分，2024 年和 2031 年）
  • 肿瘤学
  • 心血管
  • 骨科
  • 伤口管理
  • 其他应用

第十一章：细胞疗法市场分析及最终用户划分

  • 概述
  • 细胞疗法市场份额（按最终用户划分），2024 年和 2031 年（%）
  • 医院
  • 研究机构
  • 其他的

第十二章：细胞疗法市场及地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
  • 中东和非洲
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第十三章：新冠疫情对全球细胞治疗市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 中东和非洲
  • 南美洲和中美洲

第十四章：细胞疗法市场及产业概况

  • 概述
  • 市场中各公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机物发展
    • 概述

第十五章：公司简介

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • JCR Pharmaceuticals Co. Ltd.
  • Smith and Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells
  • Stemedica Cell Technologies, Inc
  • Castle Creek Biosciences, Inc.

第十六章：附录

简介目录
Product Code: TIPRE00009666

The cell therapy market is anticipated to grow from US$ 10.28 billion in 2024 to US$ 16.72 billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.2% during the period from 2031 to 2031. Key trends driving this market include advancements in cell-based therapeutics and the launch of innovative products by leading manufacturers.

Analysis of the Cell Therapy Market

Regenerative therapies promote the regeneration of cells, tissues, and organs, facilitating the restoration of their functions. As reported by the Alliance for Regenerative Medicine, there were 520 clinical trials involving cell therapy medicines globally as of Q4 2023 (comprising 192 Phase I, 125 Phase II, and 36 Phase III trials). The approval and commercialization of Kymriah in 2017, the first of its kind in cell therapy, marked a pivotal moment that has bolstered the significance of cell therapy within the cell and gene therapy sector. The advent of CAR-T cell (chimeric antigen receptor T cell) therapy has revolutionized cancer treatment approaches. CAR-T cell therapies have seen extensive research and innovation, with five additional products-Yescarta, Abecma, Tecartus, Breyanzi, and Carvykti-receiving approval for various blood cancers. Consequently, the expanding applications of regenerative medicine are propelling the growth of the cell therapy market.

Overview of the Cell Therapy Market

CAR T-cell therapy has emerged as a promising cancer treatment modality. Each year, numerous preclinical and clinical trials are conducted to explore its potential in new therapeutic applications. Future research is expected to focus on both autologous and allogeneic products, as well as new in-vivo CAR-T cell gene therapies and their effectiveness in conditions beyond hematologic malignancies.

Strategic Insights

Drivers and Opportunities in the Cell Therapy Market

Rising Cancer Prevalence Fuels Market Expansion

Factors such as sedentary lifestyles and dietary changes are recognized as significant risk factors for chronic diseases, including neurological disorders, cancer, autoimmune diseases, and cardiovascular diseases. The Centers for Disease Control and Prevention reports that 6 out of 10 Americans are affected by one or more chronic illnesses, including diabetes, cancer, heart disease, or stroke. Chronic diseases are leading causes of death and disability in the US. Factors like genetic predisposition, processed foods, pollution, and lifestyle changes contribute to the increasing incidence of cancer. The American Cancer Society noted nearly 19.3 million new cancer cases worldwide in 2020. In recent decades, cell therapy has emerged as a novel cancer treatment approach, where T cells are modified in a lab and then administered to target cancer cells. CAR-T cell therapy is utilized for treating adult and pediatric leukemia and certain types of lymphoma, with ongoing research into its potential for treating other cancers, including solid tumors. Thus, the rising number of cancer patients is driving demand for CAR-T cell therapies, contributing to the growth of the cell therapy market.

Funding for Research and Development

Researchers are driven to explore ways to enhance the efficacy of cell therapy, particularly given the complete response rates and progression-free survival seen in patients with relapsed/refractory malignancies who have undergone prior treatments. Investigations into factors like antigen loss that may lead to immune escape are underway, with strategies being developed to address these challenges. One promising approach involves designing cell therapies that target multiple antigens simultaneously. The California Institute for Regenerative Medicine (CIRM), the largest regenerative medicine organization globally, has allocated US$ 43.8 million to support gene therapy and stem cell research initiatives in California, funding projects across clinical, discovery, and infrastructure programs of the institute.

Segmentation Analysis of the Cell Therapy Market

Key segments contributing to the analysis of the cell therapy market include therapy type, product, technology, application, and end user.

  • The cell therapy market is categorized by therapy type into allogeneic and autologous, with the allogeneic segment holding a larger market share in 2023.
  • By product, the market is divided into consumables, equipment, and systems and software, with the equipment segment leading the market share in 2023.
  • In terms of technology, the market encompasses viral vector technology, genome editing technology, somatic cell technology, cell immortalization technology, cell plasticity technology, and three-dimensional technology.
  • By application, the market is segmented into oncology, cardiovascular, orthopedic, wound management, and other applications, with oncology holding the largest market share in 2023.
  • Based on end user, the cell therapy market is classified into research institutes, hospitals, and others, with hospitals dominating the market share in 2023.

Geographical Analysis of the Cell Therapy Market

The geographical scope of the cell therapy market report is divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. North America leads the market, with the US holding the largest share in 2023. This growth is attributed to increased research and development, along with the rising adoption of cell therapies such as stem cell, gene, and immune therapies. The growing incidence of genetic and cellular disorders, coupled with a focus on enhancing the development and manufacturing capacities of cell therapies, further supports market growth. Bayer AG has established its first Cell Therapy Launch Facility in Berkeley, aimed at delivering cell therapies to patients globally. This US$ 250 million, 100,000-square-foot facility will provide materials for late-stage clinical trials to facilitate the commercial launch of bemdaneprocel (BRT-DA01), an experimental cell therapy being tested by BlueRock Therapeutics for Parkinson's disease and other conditions. The Asia Pacific region is expected to exhibit the highest CAGR in the cell therapy market during the forecast period.

Scope of the Cell Therapy Market Report

Recent Developments in the Cell Therapy Market

The evaluation of the cell therapy market is based on qualitative and quantitative data obtained from primary and secondary research, including significant corporate publications, association data, and databases. Some recent developments in the cell therapy market include:

  • Ginkgo Bioworks, a company focused on building a leading platform for cell programming and biosecurity, announced the acquisition of Modulus Therapeutics' cell therapy platform assets, which include their CAR and switch receptor libraries. (Source: Ginkgo Bioworks Company Name, Press Release, 2024)
  • AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company that develops innovative cell therapies for cancer and autoimmune diseases. (Source: AstraZeneca Company Name, Press ReleaseNewsletter, 2024)

Coverage and Deliverables of the Cell Therapy Market Report

The report titled "Cell Therapy Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Cell therapy market size and forecast at global, regional, and country levels for all key market segments included in the scope.
  • Trends in the cell therapy market along with market dynamics such as drivers, restraints, and key opportunities.
  • In-depth PEST/Porter's Five Forces and SWOT analysis.
  • Analysis of the cell therapy market covering key trends, global and regional frameworks, major players, regulations, and recent market developments.
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments in the cell therapy market.
  • Detailed profiles of key companies in the market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Cell Therapy Market and By Therapy Type
    • 1.3.2 Global Cell Therapy Market and By Product
    • 1.3.3 Global Cell Therapy Market and By Technology
    • 1.3.4 Global Cell Therapy Market and By Application
    • 1.3.5 Global Cell Therapy Market and By End User
    • 1.3.6 Global Cell Therapy Market and By Geography

2. Cell Therapy Market and Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Cell therapyand Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America and PEST Analysis
    • 4.2.2 Europeand PEST Analysis
    • 4.2.3 Asia Pacificand PEST Analysis
    • 4.2.4 Middle East and Africa and PEST Analysis
    • 4.2.5 South and Central America and PEST Analysis
  • 4.3 Expert Opinions

5. Global Cell Therapy Market and Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Chronic Diseases
    • 5.1.2 Rising Adoption of Regenerative Medicines
    • 5.1.3 Increasing Number of Approvals for Cell-Based Therapies
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Cell Therapy Manufacturing
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Shift Toward Automated Cell Therapy Manufacturing
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cell therapy Market and Global Analysis

  • 6.1 Global Cell therapy Market Revenue Forecast And Analysis
  • 6.2 Global Cell therapy Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning

7. Cell therapy Market Analysis and By Therapy Type

  • 7.1 Overview
  • 7.2 Cell therapy Market Revenue Share, by Therapy Type (2024 and 2031)
  • 7.3 Allogeneic
    • 7.3.1 Overview
    • 7.3.2 Allogeneic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Autologous
    • 7.4.1 Overview
    • 7.4.2 Autologous: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

8. Cell therapy Market Analysis and By Product

  • 8.1 Overview
  • 8.2 Cell therapy Market Revenue Share, by Product (2024 and 2031)
  • 8.3 Consumables
    • 8.3.1 Overview
    • 8.3.2 Consumables: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Equipment
    • 8.4.1 Overview
    • 8.4.2 Equipment: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Systems and Software
    • 8.5.1 Overview
    • 8.5.2 Systems and Software: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

9. Cell therapy Market Analysis and By Technology

  • 9.1 Overview
  • 9.2 Cell therapy Market Revenue Share, by Technology (2024 and 2031)
  • 9.3 Viral Vector Technology
    • 9.3.1 Overview
    • 9.3.2 Viral Vector Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Genome Editing Technology
    • 9.4.1 Overview
    • 9.4.2 Genome Editing Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Somatic Cell Technology
    • 9.5.1 Overview
    • 9.5.2 Somatic Cell Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Cell Immortalization Technology
    • 9.6.1 Overview
    • 9.6.2 Cell Immortalization Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Cell Plasticity Technology
    • 9.7.1 Overview
    • 9.7.2 Cell Plasticity Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Three-Dimensional Technology
    • 9.8.1 Overview
    • 9.8.2 Three-Dimensional Technology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

10. Cell therapy Market Analysis and By Application

  • 10.1 Overview
  • 10.2 Cell therapy Market Revenue Share, by Application (2024 and 2031)
  • 10.3 Oncology
    • 10.3.1 Overview
    • 10.3.2 Oncology: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Cardiovascular
    • 10.4.1 Overview
    • 10.4.2 Cardiovascular: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Orthopedic
    • 10.5.1 Overview
    • 10.5.2 Orthopedic: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Wound Management
    • 10.6.1 Overview
    • 10.6.2 Wound Management: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 10.7 Other Applications
    • 10.7.1 Overview
    • 10.7.2 Other Applications: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

11. Cell therapy Market Analysis and By End User

  • 11.1 Overview
  • 11.2 Cell therapy Market Share, by End User, 2024 and 2031, (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Research Institutes
    • 11.4.1 Overview
    • 11.4.2 Research Institutes: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Cell therapy Market and Revenue and Forecast to 2031 (US$ Million)

12. Cell therapy Market and Geographic Analysis

  • 12.1 North America: Cell Therapy Market
    • 12.1.1 Overview
    • 12.1.2 North America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.1.3 North America: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.1.4 North America: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.1.5 North America: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.1.6 North America: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.1.7 North America: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.8 North America: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.1.9 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.1 US: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.2 US: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.3 US: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.4 US: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.5 US: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.9.6 US: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.10 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.1 Canada: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.2 Canada: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.3 Canada: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.4 Canada: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.5 Canada: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.10.6 Canada: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.1.11 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.1 Mexico: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.2 Mexico: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.3 Mexico: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.4 Mexico: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.5 Mexico: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.1.11.6 Mexico: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.2 Europe: Cell therapy Market
    • 12.2.1 Overview
    • 12.2.2 Europe: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.2.3 Europe: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
    • 12.2.4 Europe: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 12.2.5 Europe: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
    • 12.2.6 Europe: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 12.2.7 Europe: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.8 Europe: Cell therapy Market, by Country, 2024 and 2031 (%)
    • 12.2.9 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.1 Germany: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.2 Germany: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.3 Germany: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.4 Germany: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.5 Germany: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.9.6 Germany: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.10 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.1 France: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.2 France: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.3 France: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.4 France: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.5 France: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.10.6 France: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.11 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.1 UK: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.2 UK: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.3 UK: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.4 UK: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.5 UK: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.11.6 UK: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.12 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.1 Italy: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.2 Italy: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.3 Italy: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.4 Italy: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.5 Italy: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.12.6 Italy: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
    • 12.2.13 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.1 Spain: Cell therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.2 Spain: Cell Therapy Market, by Therapy Type and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.3 Spain: Cell Therapy Market, by Product and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.4 Spain: Cell Therapy Market, by Technology and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.5 Spain: Cell Therapy Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 12.2.13.6 Spain: Cell Therapy Market, By End User and Revenue and Forecast to 2031 (USD Million)
  • 12.3 Asia Pacific: Cell Therapy Market
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
    • 12.3.3 Asia Pacific: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.3.4 Asia Pacific: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.3.5 Asia Pacific: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.3.6 Asia Pacific: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.3.7 Asia Pacific: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.8 Asia Pacific: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.3.9 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.9.1 China: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.9.2 China: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.9.3 China: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.9.4 China: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.9.5 China: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.9.6 China: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.10 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.10.1 Japan: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.10.2 Japan: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.10.3 Japan: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.10.4 Japan: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.10.5 Japan: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.10.6 Japan: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.11 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.11.1 India: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.11.2 India: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.11.3 India: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.11.4 India: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.11.5 India: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.11.6 India: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.12 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.12.1 South Korea: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.12.2 South Korea: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.12.3 South Korea: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.12.4 South Korea: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.12.5 South Korea: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.12.6 South Korea: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.3.13 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.13.1 Australia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.3.13.2 Australia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.3.13.3 Australia: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.3.13.4 Australia: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.3.13.5 Australia: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.3.13.6 Australia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.4 Middle East and Africa: Cell Therapy Market
    • 12.4.1 Overview
    • 12.4.2 Middle East and Africa: Cell Therapy Market - Revenue and Forecast to 2031 (USD Million)
    • 12.4.3 Middle East and Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
    • 12.4.4 Middle East and Africa: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
    • 12.4.5 Middle East and Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
    • 12.4.6 Middle East and Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
    • 12.4.7 Middle East and Africa: Cell Therapy Market, by End-User, 2018and2031 (USD Million)
    • 12.4.8 Middle East and Africa: Cell Therapy Market, by Country, 2019 and 2031 (%)
    • 12.4.9 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.9.1 UAE: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.9.2 UAE: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.9.3 UAE: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
      • 12.4.9.4 UAE: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
      • 12.4.9.5 UAE: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.9.6 UAE: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.4.10 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.10.1 Saudi Arabia: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.10.2 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.10.3 Saudi Arabia: Cell Therapy Market, by Product, 2018and2031 (USD Millions)
      • 12.4.10.4 Saudi Arabia: Cell Therapy Market, by Technology, 2018and2031 (USD Millions)
      • 12.4.10.5 Saudi Arabia: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.10.6 Saudi Arabia: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.4.11 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.11.1 South Africa: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.4.11.2 South Africa: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Millions)
      • 12.4.11.3 South Africa: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.4.11.4 South Africa: Cell Therapy Market, by Technology, 2018and2031 (USD Million)
      • 12.4.11.5 South Africa: Cell Therapy Market, by Application, 2018and2031 (USD Million)
      • 12.4.11.6 South Africa: Cell Therapy Market, by End User, 2018and2031 (USD Million)
  • 12.5 South and Central America: Cell Therapy Market
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
    • 12.5.3 South and Central America: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
    • 12.5.4 South and Central America: Cell Therapy Market, by Product, 2018and2031 (USD Million)
    • 12.5.5 South and Central America: Cell Therapy Market, by Technology 2018and2031 (USD Million)
    • 12.5.6 South and Central America: Cell Therapy Market, by Application 2018and2031 (USD Million)
    • 12.5.7 South and Central America: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.5.8 South and Central America: Cell Therapy Market, by Country, 2024 and 2031 (%)
    • 12.5.9 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.9.1 Brazil: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.9.2 Brazil: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.5.9.3 Brazil: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.5.9.4 Brazil: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.5.9.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.5.9.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)
    • 12.5.10 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.10.1 Argentina: Cell Therapy Market and Revenue and Forecast to 2031 (USD Million)
      • 12.5.10.2 Argentina: Cell Therapy Market, by Therapy Type, 2018and2031 (USD Million)
      • 12.5.10.3 Argentina: Cell Therapy Market, by Product, 2018and2031 (USD Million)
      • 12.5.10.4 Argentina: Cell Therapy Market, by Technology 2018and2031 (USD Million)
      • 12.5.10.5 Brazil: Cell Therapy Market, by Application 2018and2031 (USD Million)
      • 12.5.10.6 Brazil: Cell Therapy Market, by End User, 2018and2031 (USD Million)

13. Impact of COVID-19 Pandemic on Global Cell Therapy Market

  • 13.1 North America: Impact Assessment of COVID-19 Pandemic
  • 13.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Cell Therapy Marketand Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies Done by the Companies in the Market, (%)
  • 14.3 Organic Developments
    • 14.3.1 Overview
  • 14.4 Inorganic Developments
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Vericel Corporation
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 MEDIPOST
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 NuVasive, Inc.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Mesoblast Limited
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 JCR Pharmaceuticals Co. Ltd.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Smith and Nephew
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Bristol-Myers Squibb Company
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Cells for Cells
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Stemedica Cell Technologies, Inc
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Castle Creek Biosciences, Inc.
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms